PR39, a peptide regulator of angiogenesis

Nature Medicine

Volumn 6, Issue 1, 2000, Pages 49-55

  Li, Jian ^a   Post, Mark ^a   Volk, Rudiger ^a   Gao, Youhe ^a   Li, Min ^a   Metais, Caroline ^a   Sato, Kaori ^a   Tsai, Jo ^a   Aird, William ^a   Rosenberg, Robert D ^b   Hampton, Thomas G ^a   Li, Jianyi ^a   Sellke, Frank ^a   Carmeliet, Peter ^c   Simons, Michael ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE; PR 39; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INFLAMMATION; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; TISSUE INJURY;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; AORTA; CAPILLARIES; CATTLE; CELL HYPOXIA; CELLS, CULTURED; CORONARY VESSELS; CYSTEINE ENDOPEPTIDASES; DNA-BINDING PROTEINS; ENDOTHELIUM, VASCULAR; HEART; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MULTIENZYME COMPLEXES; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; NEOVASCULARIZATION, PHYSIOLOGIC; NUCLEAR PROTEINS; PEPTIDES; PROTEASOME ENDOPEPTIDASE COMPLEX; RECOMBINANT PROTEINS; SWINE; TRANSCRIPTION FACTORS; UBIQUITINS; UMBILICAL VEINS; VON WILLEBRAND FACTOR;

ANIMALIA;

EID: 0033970878     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/71527     Document Type: Article

References (34)

1. Ware, J.A. & Simons, M. Angiogenesis in ischemic heart disease. Nature Med. 3, 158-164 (1997).
2. Arras, M. et al. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J. Clin. Invest. 101, 40-50 (1998).
3. Arras, M. et al. Tumor necrosis factor-alpha is expressed by monocytes/macrophages following cardiac microembolization and is antagonized by cyclosporine. Basic Res. Card. 93, 97-107 (1998).
4. Gordon, S., Clarke, S., Greaves, D. & Doyle, A. Molecular immunobiology of macrophages: recent progress. Curr. Opin. Immunol. 7, 24-33 (1995).
5. Sunderkotter, C., Goebeler, M., Schulze-Osthoff, K., Bhardwaj, R. & Sorg, C. Macrophage-derived angiogenesis factors. Pharm Ther. 51, 195-216 (1991).
6. Agerberth, B. et al. Amino acid sequence of PR-39. Isolation from pig intestine of a new member of the family of proline-arginine-rich antibacterial peptides. Eur. J. Biochem. 202, 849-54 (1991).
7. Gallo, R.L. et al. Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds. Proc. Natl. Acad. Sci. USA 91, 11035-11039 (1994).
8. Li, J., Brown, L.F., Laham, R.J., Volk, R. & Simons, M. Macrophage-dependent regulation of syndecan gene expression. Circ. Res. 81, 785-796 (1997).
9. Gudmundsson, G.H. et al. Structure of the gene for porcine peptide antibiotic PR-39, a cathelin gene family member: comparative mapping of the locus for the human peptide antibiotic FALL-39. Proc. Natl. Acad. Sci. USA 92, 7085-7089 (1995).
10. Cas. J. Biol. Chem. 273, 28978-28985 (1998).
11. max. Proc. Natl. Acad. Sci. USA 93, 6014-6018 (1996).
12. Carmeliet, P. et al. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394, 485-490 (1998); erratum 395, 525 (1998).
13. Martin, C. et al. Cardiac hypertrophy in chronically anemic fetal sheep: Increased vascularization is associated with increased myocardial expression of vascular endothelial growth factor and hypoxia-inducible factor 1. Am. J. Obstet Gynecol. 178, 527-534 (1998).
14. Gerber, H.P., Condorelli, F., Park, J. & Ferrara, N. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J. Biol. Chem 272, 23659-23667 (1997).
15. Salceda, S. & Caro, J. Hypoxia-inducible factor 1α (HIF-1α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J. Biol. Chem. 272, 22642-22647 (1997)
16. Huang, L.E., Cu, J., Schau, M. & Bunn, H.F. Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA 95, 7987-7992 (1998).
17. Kallio, P.J., Wilson, W.J., O'Brien, S., Makino, Y. & Poellinger, L. Regulation of the hypoxia-inducible transcription factor 1 alpha by the ubiquitin-proteasome pathway. J. Biol. Chem. 274, 6519-6525 (1999).
18. Ng, W.A., Crupp, I.L., Subramaniam, A. & Robbins, J. Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart. Circ Res. 68, 1742-1750 (1991).
19. Aird, W.C., Jahroudi, N., Weiler-Guettler, H., Rayburn, H.B. & Rosenberg, R.D. Human von Willebrand factor gene sequences target expression to a subpopulation of endothelial cells in transgenic mice. Proc. Natl. Acad Sci. USA 92, 4567-4571 (1995).
20. Fenteany, G. & Schreiber, S.L. Lactacystin, proteasome function, and cell fate J. Biol. Chem. 273, 8545-8548 (1998).
21. Lee, D.H. & Goldberg, A.L. Proteasome inhibitors cause induction of heat shock proteins and trehalose, which together confer thermotolerance in Saccharomyces cerevisiae. Mol. Cell. Biol. 18, 30-38 (1998).
22. Bush, K.T., Goldberg, A.L. & Nigam, S.K. Proteasome inhibition leads to a heat-shock response, induction of endoplasmic reticulum chaperones, and thermotolerance. J. Biol. Chem. 272, 9086-9092 (1997).
23. Meriin, A.B., Gabai, V.L., Yaglom, J., Shifrin, V.I. & Sherman, M.Y. Proteasome inhibitors activate stress kinases and induce Hsp72. Diverse effects on apoptosis. J. Biol. Chem. 273, 6373-6379 (1998).
24. Shen, B.Q. et al. Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro. J. Biol. Chem 273, 29979-29985 (1998).
25. Kroll, J. & Waltenberger, J. VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR). Biochem. Biophys. Res. Commun. 252, 743-746 (1998).
26. Bouloumie, A., Schini-Kerth, V.B. & Busse, R. Vascular endothelial growth factor up-regulates nitric oxide synthase expression in endothelial cells. Cardio. Res. 41, 773-780 (1999).
27. Bein, K. et al. c-Myb function in fibroblasts. J. Cell. Phys. 173, 319-326 (1997).
28. Hughes, S.E. Functional characterization of the spontaneously transformed human umbilical vein endothelial cell line ECV304: use in an in vitro model of angiogenesis. Exp. Cell. Res. 225, 171-185 (1996).
29. Dhanabal, M. et al. Endostatin: yeast production, mutants, and antitumor effect in renal cell carcinoma. Cancer Res. 59, 189-197 (1999).
30. Passaniti, A. et al. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab. Invest. 67, 519-528 (1992).
31. Guillot, P.V. et al. A vascular bed-specific pathway. J. Clin. Invest. 103, 799-805 (1999).
32. Li, J., Hampton, T., Morgan, J.P. & Simons, M. Stretch-induced VEGF expression in the heart. J. Clin. Invest. 100, 18-24 (1997).
33. Maulik, N. et al. Nitric oxide signaling in ischemic heart. Cardio. Res. 30, 593-601 (1995).
34. Sellke, F.W. et al. Angiogenesis induced by acidic fibroblast growth factor as an alternative method of revascularization for chronic myocardial ischemia. Surgery 120, 182-188 (1996).